6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity-Reference-Cited by-同舟云学术

6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity

Published:2018-08 Issue: Volume:156 Page:652-665
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Lei,Tang Jing,Huber Andrew D.,Casey Mary C.,Kirby Karen A.,Wilson Daniel J.,Kankanala Jayakanth,Xie Jiashu,Parniak Michael A.,Sarafianos Stefan G.,Wang Zhengqiang^ORCID

Funder

National Institutes of Health

University of Minnesota

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference41 articles.

1. Current status and prospects of HIV treatment;Cihlar;Curr. Opin. Virol.,2016

2. Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials*;Stephan;HIV Med.,2013

3. Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition;Sarafianos;J. Mol. Biol.,2009

4. Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine;Cihlar;Antivir. Res.,2010

5. Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009);de Bethune;Antivir. Res.,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy;Molecules;2024-05-03

2. Polyoxometalate catalysts for the synthesis of N-heterocycles;Polyoxometalates;2024-03

3. Targeting Ribonucleases with Small Molecules and Bifunctional Molecules;ACS Chemical Biology;2023-06-29

4. Strategies and Methods for the Synthesis of 2‐Pyrazolines: Recent Developments (2012–2022);Advanced Synthesis & Catalysis;2023-06-02

5. Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H;European Journal of Medicinal Chemistry;2023-03